Liraz Cohen-Biton | Health Professions | Best Researcher Award

Dr. Liraz Cohen-Biton | Health Professions | Best Researcher Award

Ashkelon Academic College | Israel

Author profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Liraz Cohen-Biton embarked on her academic journey at Sapir Academic College, where she earned a Bachelor of Social Work (B.S.W) degree in 2010. She continued her studies at Ben-Gurion University of the Negev, obtaining a Master of Social Work (M.S.W) in 2012, followed by a research thesis completed in 2019. Her academic dedication culminated in a Ph.D. from the Faculty of Health Systems Management at Ariel University in Samaria in 2022. Currently, she is furthering her education with a postdoctoral fellowship at the School of Social Work and Social Welfare, The Hebrew University of Jerusalem, from 2023 to 2025.

Professional Endeavors 🏛️

Dr. Cohen-Biton has held various academic and administrative positions. She serves as a Teaching Fellow at Ashkelon Academic College's Faculty of Social Work and has been a Lecturer and Pedagogical Coordinator for the Dog Training Course and Rehabilitative Kennels at Sapir Academic College since 2018. Her roles extend to coordination responsibilities, including retraining interviews for bachelor's degrees and practical social work training at Ashkelon Academic College.

Contributions and Research Focus 🔬

Dr. Cohen-Biton's research focuses on trauma, resilience, and chronic illness, particularly fibromyalgia. She has published several significant works, including studies on the effects of the Fibrotherapy model on women with fibromyalgia, resilience among fibromyalgia patients in conflict zones, and coping mechanisms in chronic illness. Her research has been featured in reputable journals such as BioMed, Psychology, Health & Medicine, and the International Journal of Environmental Research and Public Health.

Accolades and Recognition 🏆

Dr. Cohen-Biton has received numerous awards and grants, reflecting her impact in the academic community. She was awarded a Ph.D. graduation grant from Ariel University in Samaria in 2022 and a Doctorate honors grant in 2023. Her scholarly work has been recognized for its contribution to understanding and treating chronic conditions and trauma.

Impact and Influence 🌍

Dr. Cohen-Biton's work has had a significant impact on social work practices, particularly in the areas of trauma and chronic illness. Her innovative Fibrotherapy model has provided new insights into the treatment of fibromyalgia, improving the quality of life for many patients. Her involvement in academic administration and teaching has also influenced the next generation of social workers, particularly in areas requiring sensitivity to trauma and resilience.

Legacy and Future Contributions 🌟

As Dr. Cohen-Biton continues her postdoctoral research, her legacy is being built on the foundation of resilience and innovation in social work. Her ongoing work promises to further enhance the understanding of chronic illness management and trauma intervention, solidifying her position as a leading figure in these fields.

 

Publications


  • 📄Article: "Resilience and Sense of Coherence among Female Fibromyalgia Patients Living in a Conflict Zone Who Underwent Fibrotherapy Intervention"
    Authors: Liraz Cohen-Biton, Dan Buskila, Rachel Nissanholtz-Gannot
    Journal: BioMed
    Year: 2024

  • 📄Article: "Problem-oriented coping and resilience among Fibromyalgia patients who live under security threats and have undergone a Fibrotherapy intervention program"
    Authors: Cohen-Biton, L., Buskila, D., Nissanholtz-Gannot, R.
    Journal: Psychology, Health and Medicine
    Year: 2024

  • 📄Article: "“Here I’m Black, there I’m White”: Israeli social-workers retrospective perspective on intercultural encounters in India and Ethiopia during their training"
    Authors: Cohen-Biton, L., Malka, M.
    Journal: Social Work Education
    Year: 2023

  • 📄Article: "Review of Fibromyalgia (FM) Syndrome Treatments"
    Authors: Cohen-Biton, L., Buskila, D., Nissanholtz-Gannot, R.
    Journal: International Journal of Environmental Research and Public Health
    Year: 2022

  • 📄Article: "The Effect of the Fibrotherapy Intervention Program on the Coping Patterns of Fibromyalgia Patients" 📄
    Authors: Cohen-Biton, L., Buskila, D., Nissanholtz-Gannot, R.
    Journal: Journal of Clinical Rheumatology
    Year: 2022

  • 📄Article: "The correlation between problem-oriented coping and a sense of coherence among fibromyalgia patients who underwent the fibrotherapy model intervention programme"
    Authors: Cohen-Biton, L., Buskila, D., Nissanholtz-Gannot, R.
    Journal: Clinical and Experimental Rheumatology
    Year: 2022

 

Filippo Carannante | Medicine and Dentistry | Best Research Award

Dr. Filippo Carannante | Medicine and Dentistry | Best Research Award 

UOC Chirurgia Colorettale, Fondazione Policlinico Campus Bio-Medico di Roma | Italy 

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Filippo Carannante's academic journey began at the Bio-Medico Campus University of Rome, where he graduated with a degree in Medicine and Surgery, achieving a perfect score of 110/110 cum laude. He completed a specialized training program in General Surgery Residency at the same institution, culminating in a thesis on the oncological outcomes of rectal cancer patients. He further enhanced his expertise with various fellowships and specialized courses, including a PhD program in Biomedical Sciences and Bioethics focused on osteo-oncological diseases.

💼 Professional Endeavors

Dr. Carannante has held several prestigious positions in the field of colorectal and oncological surgery. Since November 2021, he has been a consultant colorectal surgeon at the Campus Bio-Medico Polyclinic Foundation of Rome. In September 2023, he was appointed a professor of Oncological and Digestive Surgery at the Campus Bio-Medico University of Rome. He is also an active member of the Italian Society of Colorectal Surgery (SICCR) and the Italian Society of Surgical Oncology (SICO), where he serves on the young boards, and is part of the Lower GI Group at the American College of Surgeons (ACS).

🔬 Contributions and Research Focus

Dr. Carannante's research contributions are significant, particularly in the areas of colorectal surgery and minimally invasive surgical techniques. His work includes innovative studies on the outcomes of rectal cancer treatments and the feasibility of minimally invasive colectomy in fragile patients. He has also contributed to advancements in laparoscopic and abdominal wall surgery, and has been involved in multiple research projects at renowned institutions across Europe.

🏆 Accolades and Recognition

Dr. Carannante has received numerous awards for his contributions to surgery and research. Notably, he was awarded the "Ettore Ruggieri" Scholarship by the Italian Society of Surgery (SIC) in 2023 and the "Francesco Mazzeo" Award by the Italian Society of Pathology of the Digestive System (SIPAD) in 2024. Additionally, he received the "Best Oral Presentation" award at a national congress for his study on minimally invasive colectomy.

🌍 Impact and Influence

Dr. Carannante's influence extends beyond his immediate professional environment. He serves on the editorial boards of several prestigious journals, including the International Journal of Colorectal Disease and the World Journal of Surgical Oncology. His h-index of 15 and over 828 citations highlight the impact of his research on the global medical community. He is also a reviewer for numerous scientific publications, ensuring the quality and advancement of research in his field.

🏅 Legacy and Future Contributions

Dr. Carannante's legacy is marked by his dedication to advancing the field of colorectal and oncological surgery through both clinical practice and research. His ongoing roles in various surgical societies and academic institutions position him to continue making significant contributions to the medical field. His commitment to education, research, and clinical excellence ensures that his influence will be felt for years to come, inspiring future generations of surgeons and researchers.

 

Publications 📄


📄Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis
Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
Journal: [Special Issue: Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery], Year : 2024


📄Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)
Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
Journal: Surgical Endoscopy, Year : 2024


📄Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study
Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
Journal: British Journal of Surgery, Year : 2024


📄Long-term patient-reported outcomes after anti-reflux surgery for gastroesophageal reflux disease and hiatal hernia repair: a single-center experience
Authors: Peltrini, R., Carannante, F., Giovine, G., Capolupo, G.T., Borzomati, D.
Journal: Minerva Surgery, Year : 2023


📄Surgeons’ practice and preferences for the anal fissure treatment: results from an international survey
Authors: Balla, A., Saraceno, F., Shalaby, M., Ziprin, P., Zizzo, M.
Journal: Updates in Surgery, Year : 2023


 

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

 

Notable Publications

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic 2024 (2)

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

 

 

 

 

 

Feifei Feng | Health Professions | Best Researcher Award

Dr. Feifei Feng | Health Professions | Best Researcher Award 

The Second Hospital of Shandong University | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Feifei Feng embarked on her academic journey in clinical medicine, obtaining a Master's degree through a seven-year program at Zhejiang University (2005-2012). She continued her education with a Doctor of Medicine (MD) degree in Internal Medicine from Qilu Medical College, Shandong University (2017-2020). Her academic training laid a robust foundation in both clinical and research aspects of internal medicine, particularly focusing on respiratory and critical care.

Professional Endeavors

Dr. Feng's professional career has been marked by her role as an Associate Chief Physician in the Department of Respiratory and Critical Care Medicine at the Second Hospital of Shandong University (09/2022 - Present). In this capacity, she is responsible for the daily consultation and treatment of patients with respiratory and critical care needs. Her work emphasizes the diagnosis and management of respiratory diseases, with a particular focus on lung cancer and pulmonary fibrosis.

Contributions and Research Focus

Dr. Feng's research has significantly contributed to understanding and treating respiratory diseases. Her research focus includes:

*Silicosis and Pulmonary Fibrosis: Dr. Feng has extensively studied the pathogenesis of silicosis and the therapeutic effects of compounds like Tanshinone IIA in attenuating silica-induced pulmonary fibrosis.

*Cancer Therapy: Her work on the inhibitory effects of polyphyllins and their role in enhancing chemosensitivity of cancer cells to treatments like cisplatin has been groundbreaking.

*Signaling Pathways: She has delved into the molecular mechanisms underlying disease processes, such as the TGF-β1/Smad signaling pathway, EMT, NOX4 inhibition, and Nrf2/ARE signaling activation.

Accolades and Recognition

Dr. Feng's contributions to the field have been widely recognized through numerous publications in high-impact journals. Some of her notable works include:

"Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA" (Biomed Pharmacother, 2024).

"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling" (Chem Biol Interact, 2020).

Impact and Influence

Dr. Feng's research has had a profound impact on the medical community's understanding of respiratory diseases and their treatment. Her studies on the molecular pathways involved in pulmonary fibrosis and cancer therapy have opened new avenues for developing targeted treatments. By elucidating the mechanisms of disease and identifying potential therapeutic agents, her work has contributed to improved patient outcomes and advanced the field of respiratory medicine.

Legacy and Future Contributions

Dr. Feng continues to make strides in her field through her ongoing clinical practice and research. Her dedication to understanding complex respiratory diseases and finding innovative treatments ensures that her contributions will have a lasting impact. Future research endeavors are likely to build on her current work, exploring new therapeutic targets and improving the quality of care for patients with respiratory diseases. Her legacy will be marked by her commitment to advancing medical science and improving patient health outcomes.

 

Notable Publications

Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA 2024

Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition 2019 (26)

Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling 2020 (52)

Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation 2023 (2)

Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway 2022 (8)

Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis 2021 (6)

Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway 2021 (23)

 

 

 

 

Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Dr. Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Seoul National University | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Hong Seok Kim began his academic journey with a Bachelor of Science in Engineering from Johns Hopkins University (2007-2010). He then pursued a Doctor of Medicine (M.D.) at the College of Medicine, Seoul National University (2011-2015), followed by a Ph.D. from the Graduate School, Seoul National University (2020-2022).

Professional Endeavors

Dr. Kim's professional career is marked by a series of significant positions within the Department of Orthopaedic Surgery at Seoul National University Hospital. Starting as an intern in 2015, he progressed to a resident, fellow, clinical professor, and finally, assistant professor. His roles reflect a steady advancement in his expertise and responsibilities in orthopaedic surgery.

Contributions and Research Focus

Dr. Kim has made substantial contributions to orthopaedic surgery, particularly focusing on hip arthroplasty, osteonecrosis, sarcopenia, and periprosthetic joint infections. His research is well-documented through numerous publications in high-impact journals. He has explored various aspects of orthopaedic surgery, from the biomechanics of hip replacements to the management of complex fractures and the implications of sarcopenia in elderly patients.

Accolades and Recognition

Dr. Kim's work has been recognized with several prestigious awards, including:

  • Best Presentation Award from the Korean Sarcopenia Association (2021)
  • Manrye Award from the Korean Orthopedic Association (2021)
  • International Scholar Award from the Korean Hip Society (2022)
  • Multiple CiOS reviewer Awards from the Korean Orthopedic Association (2022, 2023)
  • Best Podium Award from the Korean Hip Society (2024)

Impact and Influence

Dr. Kim's influence extends beyond his clinical and research contributions. His involvement in various professional societies, such as the Korean Orthopedic Association, Korean Hip Society, and Korean Society for Bone and Mineral Research, underscores his commitment to advancing the field. His work has influenced clinical practices, particularly in the management of hip fractures and the use of novel implant designs in total hip arthroplasty.

Legacy and Future Contributions

Dr. Kim's legacy is built on his dedication to improving patient outcomes through innovative surgical techniques and rigorous research. As he continues to publish influential papers and participate in international collaborations, his future contributions are likely to shape the evolution of orthopaedic surgery, particularly in the areas of hip arthroplasty and the management of musculoskeletal conditions in the elderly.

 

Notable publications

Computed Tomography (CT) Evaluation of Alumina Ceramic-on-Ceramic Total Hip Arthroplasty with More than 20 years of Follow-Up: Is a Follow-Up CT Scan Necessary? 2024

Novel radiologic indices for stem type decision in total hip arthroplasty in patients with metaphyseo-diaphyseal mismatched Dorr A proximal femur 2024

Outcome and complication rate of total hip arthroplasty in patients younger than twenty years: which bearing surface should be used? 2024 (2)

Optimization of Acetabular Cup Abduction by Adjusting Pelvic Pitch 2024

A 10- to 12-year follow-up study of delta ceramic-on-ceramic total hip arthroplasty 2023 (5)

Anterior and Lateral Femoroacetabular Excursion Angles Are Helpful for Assessing Femoroacetabular Impingement Syndrome: A Cross-Sectional Cohort Study 2023 (1)

 

Tatiana Romero Arias | Health Professions | Best Researcher Award

Prof Dr. Tatiana Romero Arias | Health Professions | Best Researcher Award

European University of the Canary Islands | Spain

Author Profile

Scopus

Early Academic Pursuits

Dr. Tatiana Romero Arias began her academic journey in her native Spain, focusing on Speech Therapy at the University of La Laguna. She completed her Higher Degree in Speech Therapy in 2014, followed by a Master's in Cognitive Neuroscience and Specific Support Needs in 2015. She continued her academic pursuits with an additional Master's in Voice Rehabilitation from the Autonomous University of Barcelona in 2016. Her educational trajectory culminated in a doctoral degree in Psychology from the University of La Laguna in 2021.

Professional Endeavors

Dr. Romero Arias' professional career is marked by significant contributions in research and academia. She served as Research Staff in Training at the University of La Laguna and later as Postdoctoral Research Staff at the Ministry of Science and Innovation. Currently, she holds the position of Assistant Professor Doctor at the Pontifical University of Salamanca, specializing in Speech Therapy within the Faculty of Health Sciences.

Contributions and Research Focus

Her research focuses on various aspects of Speech Therapy and Cognitive Neuroscience, with notable contributions in voice rehabilitation, neurological disorders affecting speech, and educational practices in the field of speech therapy. She has led and participated in several research projects exploring these areas, including studies on vocal tract exercises and the rehabilitation of speech post-COVID-19.

Accolades and Recognition

Dr. Romero Arias has garnered recognition for her scholarly work, evidenced by her publications in reputable journals such as the Journal of Speech Therapy Research and Majorensis. Her contributions to the field have been acknowledged through invitations to speak at seminars and conferences, both nationally and internationally.

Impact and Influence

Her work has had a tangible impact on both academic discourse and clinical practice in Speech Therapy. By exploring innovative approaches to therapy and contributing to educational initiatives, she has shaped the way professionals approach speech rehabilitation and neurological disorders.

Legacy and Future Contributions

Looking ahead, Dr. Romero Arias continues to expand her research agenda, aiming to further integrate technological advancements into clinical practice and educational frameworks. Her dedication to mentoring students and her involvement in international research collaborations underscore her commitment to advancing the field of Speech Therapy.

Notable publications

Clinical indicators of dysphagia in patients with Parkinson disease 2024

Voice assessment and intervention in patients with Sexually Transmitted Diseases: a systematic review 2024

Biomechanical Parameters of Voice in Parkinson’s Disease Patients 2024

Efficacy of semi-occluded vocal tract exercises in essential tremor: a case study 2023

Voice Sequelae Following Recovery From COVID-19 2022 (5)

 

 

Oliver Skan | Medicine and Dentistry | Best Researcher Award

Dr. Oliver Skan | Medicine and Dentistry | Best Researcher Award

Royal Free London NHS Trust | United Kingdom

Author Profile

Orcid

Early Academic Pursuits

Dr. Oliver Skan embarked on his medical journey at Keble College, University of Oxford, where he pursued a BM BCh degree from 2014 to 2020. His academic performance was exceptional, earning him a distinction in his BM BCh and a First Class Honours in Medical Sciences. Throughout his studies, he demonstrated outstanding aptitude, securing numerous prestigious educational prizes. These include the Meakins McLaren Medal for the highest overall performance during clinical school, the Sir Roger Bannister Prize for clinical neuroscience, and the Stewart Greenall Memorial Prize for excelling in OSCE examinations. His consistent excellence also earned him the Sir Peter Morris Prize in Surgery and the Gibbs Prize for his performance in first BM examinations part II, along with a scholarship from Keble College.

Professional Endeavors

Dr. Skan's clinical experience is extensive and diverse. He began his foundation training in North Central London, where he spent four months each in General Surgery (F1) and Plastic Surgery (F2). His commitment to surgical excellence led him to a Junior Clinical Fellowship in Plastic Surgery at The Royal Free Hospital in London from August 2022 to February 2023. His skill and dedication were further recognized when he ranked first nationally in the 2023 Core Surgical Training applications, leading to his current position in Core Surgical Training from October 2023 to October 2025.

Contributions and Research Focus

Dr. Skan has made significant contributions to medical research, particularly focusing on surgical outcomes and medical education. His research on gender-based discrimination and sexual harassment among medical students was published in Medical Teacher in 2024. He has also been actively involved in the STARSurg initiative, where he coordinated data collection for the RECON study, demonstrating his leadership and data management skills. His work has been published in reputable journals such as the British Journal of Anaesthesia and the British Journal of Surgery.

Accolades and Recognition

Dr. Skan's academic and professional journey is marked by numerous accolades. His educational achievements at Oxford are complemented by recognition for his teaching excellence, such as the Certificate of Merit from Whittington Hospital. His research presentations and posters have been well-received at various national and international conferences, showcasing his ability to contribute valuable insights to the medical community.

Impact and Influence

Dr. Skan has significantly influenced medical education and research. His efforts to improve clinical education through courses like 'Fantastic Bleeps and How to Field Them' have benefited numerous medical students nationally and internationally. His role in audits and quality improvement projects, such as improving UTI management through telemedicine, underscores his commitment to enhancing patient care and clinical practice.

Legacy and Future Contributions

Looking ahead, Dr. Skan's legacy is one of excellence, leadership, and dedication to medical science and education. His ongoing Core Surgical Training and involvement in significant research projects position him to make further impactful contributions to the field. As a national committee member for We Are Donors, he also plays a vital role in promoting organ donation and transplantation education. Dr. Skan's future contributions are expected to continue shaping the landscape of medical education and surgical practice, benefiting both patients and the medical community at large.

 

Notable Publications

Examining medical students’ experience of gender-based discrimination and sexual harassment from clinical teachers at a UK medical school 2024

 

 

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa's academic journey commenced with a Bachelor's in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He pursued his passion further with a Master's in Biosciences from COMSATS University Islamabad, Pakistan, where he delved into cancer genetics. Currently, he is pursuing a Ph.D. in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDs, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

Jairus has garnered diverse professional experiences, from his tenure as a Laboratory Analyst at the Regional Veterinary Investigation Laboratory, Kenya, to his role as the Head of Public Needs Research at the Integrated Cancer Research Foundation of Kenya. He has contributed significantly to cancer education and research, both as a volunteer and in leadership positions, demonstrating his commitment to advancing cancer management in Kenya.

Contributions and Research Focus

With a strong background in biochemistry, genetics, and molecular biology, Jairus has dedicated his research efforts to elucidating the roles of non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker discovery, and DNA repair mechanisms. His research spans both experimental and computational domains, aiming to unravel the complexities of cancer genetics and improve therapeutic strategies.

Accolades and Recognition

Jairus's contributions to the field of cancer genetics have been recognized internationally. He has been awarded prestigious scholarships, including the Queen Elizabeth Commonwealth Scholarship, and has received honors for his academic achievements. Additionally, his research publications in reputable journals underscore his growing influence in the scientific community.

Impact and Influence

Through his research, leadership roles, and volunteer activities, Jairus has made a significant impact on cancer education, awareness, and research in Kenya. His work has contributed to the understanding of cancer pathogenesis and has paved the way for innovative approaches to cancer management and treatment.

Legacy and Future Contributions

As Jairus continues his doctoral studies and pursues his research interests in cancer genetics, he aims to leave a lasting legacy in the field through groundbreaking discoveries and transformative contributions. His multidisciplinary approach, coupled with his passion for scientific inquiry, positions him as a promising leader in cancer research with the potential to drive positive change in the global fight against cancer.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

 

 

 

 

Jyoti Upadhyay | Health Professions | Women Research Award

Dr. Jyoti Upadhyay | Health Professions | Women Research Award

School of Health Sciences and Technology UPES | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits

Dr. Jyoti Upadhyay pursued her academic journey with a fervor for pharmaceutical sciences. Her Ph.D. from Kumaun University focused on the impact of persistent organic pollutants on birth defects. Earlier, she excelled in her M.Pharm, exploring the interaction between Rhododendron flower juice and amlodipine bioavailability.

Professional Endeavors

With a wealth of experience, Dr. Upadhyay has served in various capacities, including Associate Professor at UPES University and Coordinator at the Adverse Drug Reaction Monitoring Centre. She has also contributed significantly as an Assistant Professor and Research Scholar.

Contributions and Research Focus

Dr. Upadhyay's research spans from investigating birth defect rates to analyzing drug interactions and establishing community resilience centers. She led projects on pharmacognostic investigations and health status surveys in Uttarakhand, showcasing her diverse research interests and commitment to public health.

Accolades and Recognition

Her dedication has earned her numerous accolades, including Academic Excellence and Best Researcher Awards. Additionally, she's been recognized for her outstanding performance in academic pursuits and her contributions to scientific writing.

Impact and Influence

Dr. Upadhyay's work has made a significant impact on pharmaceutical research, public health, and academia. Through her research, teaching, and project leadership, she has influenced the understanding of drug interactions, birth defect risks, and community health resilience.

Legacy and Future Contributions

Dr. Upadhyay's legacy lies in her multifaceted contributions to pharmaceutical sciences and public health. Her future contributions are anticipated to further advance knowledge in pharmacology, drug safety, and community health, leaving a lasting impact on research, education, and societal well-being.

Notable Publications

Postpartum depression: aetiology, pathogenesis and the role of nutrients and dietary supplements in prevention and management 2023 (3)

ECG based apnea detection by multirate processing hybrid of wavelet-empirical decomposition Hjorth features extraction and neural networks 2023

A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research 2023 (5)

Degradation of Xenobiotic Pollutants: An Environmentally Sustainable Approach 2022 (21)

In vivo wound-healing and antioxidant activity of aqueous extract of Roylea elegans leaves against physically induced burn model in Wistar albino rats 2021 (4)